Allstate Corp Vertex Pharmaceuticals Inc Transaction History

Allstate Corp

$3.33 Billion
Q4 2024

A detailed history of Allstate Corp transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Allstate Corp holds 7,615 shares of VRTX stock, worth $3.45 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

7,615

Holding current value

$3.45 Million

% of portfolio

0.09%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	BUY	$396.64 - $516.74 $3.02 Million - $3.93 Million	7,615 New	7,615 $3.07 Million
Q2 2024 Aug 13, 2024	SELL	$392.81 - $485.53 $7,463 - $9,225	-19 Reduced 2.05%	906 $424,000
Q1 2024 May 10, 2024	SELL	$407.69 - $446.08 $2,446 - $2,676	-6 Reduced 0.64%	925 $386,000
Q4 2023 Feb 09, 2024	SELL	$343.0 - $410.68 $19,894 - $23,819	-58 Reduced 5.86%	931 $378,000
Q2 2023 Aug 14, 2023	BUY	$314.42 - $351.91 $1,886 - $2,111	6 Added 0.61%	989 $348,000
Q1 2023 May 10, 2023	SELL	$283.23 - $323.1 $3.3 Million - $3.77 Million	-11,653 Reduced 92.22%	983 $309,000
Q2 2022 Aug 15, 2022	SELL	$234.96 - $292.55 $1.47 Million - $1.82 Million	-6,238 Reduced 33.05%	12,636 $3.56 Million
Q1 2022 May 16, 2022	SELL	$221.42 - $260.97 $46,055 - $54,281	-208 Reduced 1.09%	18,874 $4.93 Million
Q4 2021 Feb 15, 2022	BUY	$177.01 - $223.45 $2.18 Million - $2.75 Million	12,315 Added 181.99%	19,082 $4.19 Million
Q3 2021 Nov 15, 2021	SELL	$181.39 - $202.99 $70,197 - $78,557	-387 Reduced 5.41%	6,767 $1.23 Million
Q2 2021 Aug 16, 2021	SELL	$187.49 - $221.1 $260,986 - $307,771	-1,392 Reduced 16.29%	7,154 $1.44 Million
Q1 2021 May 14, 2021	BUY	$207.02 - $241.31 $437,019 - $509,405	2,111 Added 32.8%	8,546 $1.84 Million
Q4 2020 Feb 12, 2021	SELL	$207.01 - $276.09 $283,189 - $377,691	-1,368 Reduced 17.53%	6,435 $1.52 Million
Q3 2020 Nov 13, 2020	SELL	$255.65 - $303.1 $438,439 - $519,816	-1,715 Reduced 18.02%	7,803 $2.12 Million
Q2 2020 Aug 13, 2020	BUY	$225.48 - $295.8 $57,948 - $76,020	257 Added 2.78%	9,518 $2.76 Million
Q1 2020 May 15, 2020	SELL	$199.77 - $247.81 $4.34 Million - $5.38 Million	-21,700 Reduced 70.09%	9,261 $2.2 Million
Q4 2019 Feb 14, 2020	BUY	$166.71 - $223.91 $29,007 - $38,960	174 Added 0.57%	30,961 $6.78 Million
Q3 2019 Nov 14, 2019	BUY	$166.23 - $187.09 $325,977 - $366,883	1,961 Added 6.8%	30,787 $5.22 Million
Q2 2019 Aug 14, 2019	BUY	$164.61 - $190.37 $635,888 - $735,399	3,863 Added 15.47%	28,826 $5.29 Million
Q4 2018 Feb 13, 2019	BUY	$151.91 - $192.21 $3.79 Million - $4.8 Million	24,963 New	24,963 $4.14 Million

Others Institutions Holding VRTX

# of Institutions

1,717

Shares Held

223M

Call Options Held

1.64M

Put Options Held

1.37M

Capital World Investors Los Angeles, CA

26.8M
Shares

$12.2 Billion
1.99% of portfolio
Vanguard Group Inc Valley Forge, PA

23.3M
Shares

$10.5 Billion
0.17% of portfolio
Black Rock Inc. New York, NY

21.3M
Shares

$9.66 Billion
0.23% of portfolio
State Street Corp Boston, MA

11.8M
Shares

$5.36 Billion
0.23% of portfolio
Capital Research Global Investors Los Angeles, CA

9M
Shares

$4.08 Billion
0.9% of portfolio

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $116B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Allstate Corp, based on Form 13F filings with the SEC.

News

Stay updated on Allstate Corp with notifications on news.

Account